Over 200 interstitial lung diseases, from ultra rare to relatively common, are recognised.
Most interstitial lung diseases are characterised by inflammation or fibrosis within the …

The coronavirus disease (COVID-19), caused by severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2) infection, is leading to unknown and unusual health conditions …

Pulmonary rehabilitation is a highly effective treatment for people with chronic lung disease
but remains underused across the world. Recent years have seen the emergence of new …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease characterized by
progressive lung scarring and the histological picture of usual interstitial pneumonia (UIP). It …

Although the exact prevalence of post-COVID-19 condition (also known as long COVID) is
unknown, more than a third of patients with COVID-19 develop symptoms that persist for …

This analysis extrapolates information from previous studies and experiences to bring
physical medicine and rehabilitation perspective and intervention to the multidisciplinary …

Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease.
Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is …

A growing understanding of the benefits of exercise over the past few decades has
prompted researchers to take an interest in the possibilities of exercise therapy. Because …

Background: There is no agreement about or understanding of what rehabilitation is; those
who pay for it, those who provide it, and those who receive it all have different …

Rationale: Pulmonary rehabilitation (PR) has demonstrated physiological, symptom-
reducing, psychosocial, and health economic benefits for patients with chronic respiratory …